Literature DB >> 9821655

Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.

M Sakai1, T Imai, H Ohtake, M Otagiri.   

Abstract

This study was performed to evaluate the utility of absorption enhancers with reference to mucosal cell cytotoxicity. Overall assessment of the damage to plasma, lysosomal and nuclear membranes by three absorption enhancers, sodium deoxycholate, sodium caprate and dipotassium glycyrrhizinate, was performed on Caco-2 cell monolayers. The cytotoxicities of sodium deoxycholate (0.02-0.1% w/v), sodium caprate (0.1-0.5% w/v) and dipotassium glycyrrhizinate (0.5-2% w/v) were evaluated by the trypan blue-exclusion test, the protein-release test, the neutral-red assay, the DNA--propidium iodide staining test and the test for recovery of transepithelial electrical resistance (TEER) up to 24 h after treatment with each enhancer. Sodium dodecyl sulphate (SDS; 0.1% w/v), a potent surfactant, was used as positive control. SDS at this level was significantly cytotoxic whereas dipotassium glycyrrhizinate was not cytotoxic in any tests. Results from the trypan blue-exclusion and protein-release tests showed that high concentrations of sodium caprate (0.5% w/v) and sodium deoxycholate (0.1% w/v) were significantly cytotoxic to the plasma membrane. The neutral-red assay, an indicator of damage to lysosomal membranes, revealed that 0.5% (w/v) sodium caprate had no effect whereas the uptake of neutral red was slightly increased by treatment with 0.1% (w/v) sodium deoxycholate, implying that the compound had cell-growth-enhancing activity. Nuclear-membrane damage, as evaluated by the DNA--propidium iodide staining test, was severe in cell monolayers treated with 0.5% (w/v) sodium caprate compared with that induced by 0.1% (w/v) sodium deoxycholate. In the TEER recovery test, TEER failed to recover 24 h after treatment with 0.5% (w/v) sodium caprate and 0.1% (w/v) SDS, but recovered after treatment with 0.1% (w/v) sodium deoxycholate. The recovery of TEER might be related to nuclear membrane damage and cell-growth-enhancing activity. These results indicate that of the three classes of enhancer, dipotassium glycyrrhizinate was not cytotoxic and that high concentrations of sodium caprate and sodium deoxycholate could damage plasma and nuclear membranes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821655     DOI: 10.1111/j.2042-7158.1998.tb03319.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

Review 1.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Drug Permeation Characterization of Inhaled Dry Powder Formulations in Air-Liquid Interfaced Cell Layer Using an Improved, Simple Apparatus for Dispersion.

Authors:  Ayumu Asai; Tomoyuki Okuda; Erina Sonoda; Tomoyo Yamauchi; Saki Kato; Hirokazu Okamoto
Journal:  Pharm Res       Date:  2015-10-21       Impact factor: 4.200

Review 3.  Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers.

Authors:  L González-Mariscal; P Nava; S Hernández
Journal:  J Membr Biol       Date:  2005-09       Impact factor: 1.843

4.  Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin.

Authors:  Donna S Cox; Sangeeta Raje; Huanling Gao; Noha N Salama; Natalie D Eddington
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

5.  Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers.

Authors:  Amy B Foraker; Rob J Walczak; Michael H Cohen; Tony A Boiarski; Carl F Grove; Peter W Swaan
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

6.  Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.

Authors:  Hideki Ichikawa; Nicholas A Peppas
Journal:  J Biomed Mater Res A       Date:  2003-11-01       Impact factor: 4.396

7.  Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer.

Authors:  Yogeeta Narkar; Ronald Burnette; Reiner Bleher; Ralph Albrecht; Angki Kandela; Joseph R Robinson
Journal:  Pharm Res       Date:  2007-12-27       Impact factor: 4.200

8.  In vitro interactions between the oral absorption promoter, sodium caprate (C(10)) and S. typhimurium in rat intestinal ileal mucosae.

Authors:  Alyssa B Cox; Lee-Anne Rawlinson; Alan W Baird; Victoria Bzik; David J Brayden
Journal:  Pharm Res       Date:  2007-06-02       Impact factor: 4.200

9.  Acylation of Glucagon-like peptide-2: interaction with lipid membranes and in vitro intestinal permeability.

Authors:  Sofie Trier; Lars Linderoth; Simon Bjerregaard; Thomas Lars Andresen; Ulrik Lytt Rahbek
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

10.  Protein and Peptide drug delivery: oral approaches.

Authors:  Jessy Shaji; V Patole
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.